Drug Information
Drug General Information | |||||
---|---|---|---|---|---|
Drug ID |
DXFN7G
|
||||
Drug Name |
N-(4-bromophenethyl)-N-((4-(4-cyanobenzyl)-4H-1,2,4-triazol-3-yl)methyl)quinoline-2-carboxamide
|
||||
Synonyms |
CHEMBL201315
|
||||
Indication | Discovery agent | Investigative | [1587926] | ||
Formula |
C29H23BrN6O
|
||||
Canonical SMILES |
Brc1ccc(CCN(Cc2nncn2Cc3ccc(cc3)C#N)C(=O)c4ccc5ccccc5n4)cc1
|
||||
InChI |
InChI=1S/C29H23BrN6O/c30-25-12-9-21(10-13-25)15-16-35(29(37)27-14-11-24-3-1-2-4-26(24)33-27)19-28-34-32-20-36(28)18-23-7-5-22(17-31)6-8-23/h1-14,20H,15-16,18-19H2
|
||||
InChIKey |
HBICQBWDOZPTLD-UHFFFAOYSA-N
|
||||
Target and Pathway | |||||
Target(s) | Farnesyltransferase | Target Info | [1587926] | ||
Protein farnesyltransferase beta subunit | Target Info | [1587926] | |||
NetPath Pathway | TSH Signaling Pathway | ||||
References |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.